Tuberculosis Epidemiologic Studies Consortium III

The Centers for Disease Control and Prevention seeks to identify respondents capable of developing, implementing, and evaluating intervention studies to improve identification of latent tuberculosis infection and treatment completion among high-risk non-U.S.-born populations in primary care settings. Respondents must have experience conducting similar epidemiologic research projects, and the ability to collect electronic health record data, design interventions to strengthen performance across the LTBI care cascade, submit quarterly performance reports and annual cost analyses, and publish scientific papers. Capability statements are due by March 4, 2021 to inform acquisition strategy for potential contract number 75D301-21-R-71814.

There is no set-aside designated for this potential five-year contract, with an anticipated period of performance from September 29, 2021 through September 28, 2026. The NAICS code is 541715 for research and development in the physical, engineering, and life sciences with a PSC code of R425 for epidemiologic research services. Respondents must have accessible primary care clinical practices for proposed intervention studies, and the Centers for Disease Control and Prevention will evaluate responses to determine the possibility of a small business set-aside and the requirements outlined in the attached draft statement of work, which include intervention protocols, quarterly reports, annual cost analyses, and scientific publications over optional one-year extensions to the base one-year period of performance.